It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
CSIRO and Rothschild initiative brings R&D and venture capital closer together
Media Release - Ref 2001/177 - Jul 25 , 2001
The Rothschild e-Fund, within Rothschild Australia's Venture Capital Group, has been joined by Dr Darren Cundy from CSIRO for a one year secondment, marking a significant new approach to bridging the gap between the scientific community and the venture capitalists.
Dr Cundy will work with one of Australia's leading venture capital groups in an arrangement that both organisations expect will grow the business opportunities that exist between the country's largest R&D provider and one of Australia's most respected venture capital firms.
CSIRO has been applying its mathematics expertise to develop financial derivatives products that help manage market risks.
“A major US hedge-fund firm has just commissioned us to provide exotic options models.” Dr Zhu says.....
To Dr Zhu, the value of solving the pricing problem scientifically is that it ‘takes the betting out’ of derivatives. That means an enhanced ability to differentiate risk and allocate it to those investors most able to take it. This has allowed an explosive growth in the size and complexity of the derivatives market.